Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety and Pharmacokinetic Evaluation of Zika Virus Immune Globulin in Healthy Volunteers

Trial Profile

Safety and Pharmacokinetic Evaluation of Zika Virus Immune Globulin in Healthy Volunteers

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 06 Feb 2019

At a glance

  • Drugs ZIKV IG (Primary)
  • Indications Zika virus infection
  • Focus Adverse reactions
  • Sponsors Emergent BioSolutions
  • Most Recent Events

    • 25 Jan 2019 Planned End Date changed from 1 Feb 2019 to 6 Mar 2019.
    • 25 Jan 2019 Planned primary completion date changed from 1 Feb 2019 to 6 Mar 2019.
    • 25 Jan 2019 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top